New drug cocktails tested for Tough-to-Treat blood cancer

NCT ID NCT04722146

Ongoing Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing the safety and best doses of a new drug called teclistamab when it is given alongside other existing cancer drugs. It involves 140 adults with multiple myeloma, a type of blood cancer, who have tried other treatments. The main goal is to see if these drug combinations are safe and tolerable, and to find the right doses for future research.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Alfred Health

Melbourne, 3004, Australia
CHU Nantes

Nantes, 44093, France
CHU de Bordeaux - Hospital Haut-Leveque

Pessac, 33604, France
Calvary Mater Newcastle Hospital

Waratah, 2298, Australia
Centre Leon Berard

Lyon, 69373, France
Chu Rennes Hopital Pontchaillou

Rennes, 35000, France
Colorado Blood Cancer Institute

Denver, Colorado, 80218, United States
Fred Hutchinson Cancer Center

Seattle, Washington, 98109, United States
Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States
Indiana University Melvin and Bren Simon Cancer Center

Indianapolis, Indiana, 46202, United States
Institut Universitaire du cancer de Toulouse-Oncopole

Toulouse, 31059, France
Levine Cancer Institute

Charlotte, North Carolina, 28204, United States
Medical College Of Wisconsin

Milwaukee, Wisconsin, 53226, United States
Memorial Sloan-Kettering Cancer Center

New York, New York, 10021, United States
St Vincents Hospital Melbourne

Fitzroy, 3065, Australia
Tennessee Oncology

Nashville, Tennessee, 37203, United States
The Christie Nhs Foundation Trust

Manchester, M20 4BX, United Kingdom
The Royal Marsden NHS Trust Sutton

Surrey, SM2 5PT, United Kingdom
UZ Gent

Ghent, 9000, Belgium
UZA

Edegem, 2650, Belgium
University College Hospital

London, NW1 2BU, United Kingdom
University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States
University of California San Francisco

San Francisco, California, 94143, United States
University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15232, United States
Washington University School Of Medicine

St Louis, Missouri, 63110-1032, United States
Weill Cornell Medical College

New York, New York, 10065, United States
Winship Cancer Institute Emory University

Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA